Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Income from Continuing Operations (2020 - 2025)

Rapid Micro Biosystems' Income from Continuing Operations history spans 6 years, with the latest figure at 11505000.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 1.61% year-over-year to 11505000.0; the TTM value through Sep 2025 reached 44292000.0, up 8.48%, while the annual FY2024 figure was 46889000.0, 10.63% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 11505000.0 at Rapid Micro Biosystems, up from 11858000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 9666000.0 in Q4 2024 and bottomed at 24987000.0 in Q3 2021.
  • The 5-year median for Income from Continuing Operations is 13322000.0 (2024), against an average of 14121684.21.
  • The largest annual shift saw Income from Continuing Operations plummeted 195.18% in 2021 before it surged 34.61% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 14605000.0 in 2021, then decreased by 12.61% to 16447000.0 in 2022, then skyrocketed by 32.07% to 11172000.0 in 2023, then increased by 13.48% to 9666000.0 in 2024, then decreased by 19.03% to 11505000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Income from Continuing Operations are 11505000.0 (Q3 2025), 11858000.0 (Q2 2025), and 11263000.0 (Q1 2025).